| New quinoxaline 1, 4-di-N-oxides. Part 1: Hypoxia-selective cytotoxins and anticancer agents derived from quinoxaline 1, 4-di-N-oxides KM Amin, MMF Ismail, E Noaman, DH Soliman, YA Ammar Bioorganic & medicinal chemistry 14 (20), 6917-6923, 2006 | 112 | 2006 |
| Design, synthesis and 2D QSAR study of novel pyridine and quinolone hydrazone derivatives as potential antimicrobial and antitubercular agents MA Abdelrahman, I Salama, MS Gomaa, MM Elaasser, MM Abdel-Aziz, ... European Journal of Medicinal Chemistry 138, 698-714, 2017 | 99 | 2017 |
| New quinoxaline 1, 4-di-N-oxides: Anticancer and hypoxia-selective therapeutic agents MMF Ismail, KM Amin, E Noaman, DH Soliman, YA Ammar European journal of medicinal chemistry 45 (7), 2733-2738, 2010 | 67 | 2010 |
| Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: Design, synthesis, and in vitro biological evaluation MA Said, WM Eldehna, A Nocentini, SH Fahim, A Bonardi, AA Elgazar, ... European Journal of Medicinal Chemistry 189, 112019, 2020 | 53 | 2020 |
| Synthesis, biological and molecular dynamics investigations with a series of triazolopyrimidine/triazole-based benzenesulfonamides as novel carbonic anhydrase inhibitors MA Said, WM Eldehna, A Nocentini, A Bonardi, SH Fahim, S Bua, ... European Journal of Medicinal Chemistry 185, 111843, 2020 | 43 | 2020 |
| Design, synthesis and evaluation of new quinazolin-4-one derivatives as apoptotic enhancers and autophagy inhibitors with potent antitumor activity HSA ElZahabi, MS Nafie, D Osman, NH Elghazawy, DH Soliman, ... European Journal of Medicinal Chemistry 222, 113609, 2021 | 40 | 2021 |
| Synthesis, biological evaluation and 2D-QSAR study of halophenyl bis-hydrazones as antimicrobial and antitubercular agents HA Abdel-Aziz, WM Eldehna, M Fares, STA Al-Rashood, KA Al-Rashood, ... International journal of molecular sciences 16 (4), 8719-8743, 2015 | 31 | 2015 |
| Synthesis, characterization, anti-bacterial and anti-fungal activities of new quinoxaline 1, 4-di-N-oxide derivatives DH Soliman International Journal of Organic Chemistry 3 (03), 65, 2013 | 30 | 2013 |
| Scaffold hopping and redesign approaches for quinazoline based urea derivatives as potent VEGFR-2 inhibitors SR Abd El Hadi, DS Lasheen, DH Soliman, EZ Elrazaz, KAM Abouzid Bioorganic Chemistry 101, 103961, 2020 | 23 | 2020 |
| Synthesis, in vitro and in silico studies of some novel 5-nitrofuran-2-yl hydrazones as antimicrobial and antitubercular agents HAK Abdel-Aziz, WM Eldehna, M Fares, T Elsaman, MM Abdel-Aziz, ... Biological and Pharmaceutical Bulletin 38 (10), 1617-1630, 2015 | 20 | 2015 |
| Novel 6-phenylnicotinohydrazide derivatives: design, synthesis and biological evaluation as a novel class of antitubercular and antimicrobial agents DH Soliman, WM Eldehna, HA Ghabbour, MM Kabil, MM Abdel-Aziz, ... Biological and Pharmaceutical Bulletin 40 (11), 1883-1893, 2017 | 17 | 2017 |
| Synthesis, antitumor activity, pharmacophore modeling and QSAR studies of novel pyrazoles and pyrazolo [1, 5-a] pyrimidines against breast adenocarcinoma mcf-7 cell line MMF Ismail, DH Soliman, AM Farrag, R Sabour Int J Pharm Pharm Sci 8 (7), 434-442, 2016 | 16 | 2016 |
| Synthesis and molecular modeling study of novel pyrrole Schiff Bases as anti-HSV-1 agents KMH Hilmy, DH Soliman, EBA Shahin, R Abd Alhameed Life Science Journal 9 (2), 841-850, 2012 | 14 | 2012 |
| Design, synthesis and evaluation of 1, 3, 2 diazaphosphorin [4, 5-b] quinoxaline-5, 10-di-N-oxide derivatives as novel VEGFR-2 and SRC kinase inhibitors in the treatment of … AS S Hamad Elgazwy, DH Soliman The Open Conference Proceedings Journal 4 (1), 2013 | 11 | 2013 |
| Synthesis of new arylazopyrazoles as apoptosis inducers: Candidates to inhibit proliferation of MCF‐7 cells MMF Ismail, DH Soliman, R Sabour, AM Farrag Archiv der Pharmazie 354 (1), 2000214, 2021 | 9 | 2021 |
| Regio-and diastereoselective synthesis of novel polycyclic pyrrolo [2, 1-a] isoquinolines bearing indeno [1, 2-b] quinoxaline moieties by a three-component [3+ 2]-cycloaddition … FM Moghaddam, A Moafi, B Jafari, A Vilinger, P Langer Synlett 31 (03), 267-271, 2020 | 9 | 2020 |
| Novel pyrrolo[2,3-d]pyrimidines and pyrrolo[2,3-b]pyridines: design, synthesis, and in vivo TNF-α inhibitory activity KMH Hilmy, HG Abdul-Wahab, DH Soliman, MMA Khalifa, AM Hegab Medicinal Chemistry Research 24, 2097-2110, 2015 | 7 | 2015 |
| Design, synthesis and evaluation of novel diaryl pyrrolopyrimidine and pyrrolothiazine derivatives as inhibitors of tumor necrosis factor stimulated gene-14 (TSG-14) production KMH Hilmy, DH Soliman, EBA Shahin, HS El-Deeb, SM El-Kousy European Journal of Medicinal Chemistry 78, 419-424, 2014 | 7 | 2014 |
| Design, synthesis and in-silico studies of novel chalcones as anti-prostate cancer and cathepsin B inhibitors DH Soliman, AM Farrag, O Omran Journal of Applied Pharmaceutical Science 7 (7), 010-020, 2017 | 6 | 2017 |
| The effect of intrinsic rewards on organizational citizenship behavior: applied to tourism companies in Egypt B Ibrahim, N Nassar, D Soliman Egyptian journal of tourism, 2021 | 4 | 2021 |
